Advertisement

The Adrenal Cortex

  • John T. Gwynne
  • Robert L. Ney

Abstract

The function of the adrenal cortex is to produce the appropriate steroid hormones in normal amounts. Regulatory mechanisms both within the adrenal cell and within the hypothalamic-pituitary-adrenal axis normally ensure that this function is properly performed. Production of an inappropriate kind or amount of steroid hormone results in disease. Thus, it is not surprising that diseases of the adrenal cortex are frequently the result of primary abnormalities of regulation rather than of structure. The enzymatic pathways responsible for converting substrate cholesterol into steroid hormones have been well delineated for many years.1 On the other hand, regulation of these pathways and details of their molecular mechanisms are incompletely understood. It would seem that a more thorough and accurate understanding of these processes would lead to improved diagnosis and treatment of adrenal disorders. Thus, in the preparation of this review, the relationship of recently reported basic observations to current understanding of adrenal regulation has been emphasized. It is hoped that this approach will highlight the relevance of experimental observations to clinical questions. At the same time, the intent is to provide a sufficiently detailed review of basic observations to be of use to those with investigative interest in the adrenal cortex and the endocrine glands in general.

Keywords

Adrenal Cortex Congenital Adrenal Hyperplasia Adrenal Cell ACTH Secretion ACTH Stimulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Temple, T.E., and Iiddle, G.W., 1970, Inhibitors of adrenal steroid biosynthesis, Annu. Rev. Pharmacol. 10: 199–218.PubMedGoogle Scholar
  2. 2.
    Schwyzer, R., 1977, ACTH: A short introductory review, Ann. N.Y. Acad. Sci. 297: 3–25.PubMedGoogle Scholar
  3. 3.
    Yalow, R.S., and Berson, S.A., 1971, Size heterogeneity of immunoreactive human ACTH in plasma and in extracts of pituitary glands and ACTH-producing thymoma, Biochem. Biophys. Res. Commun. 44: 439–445.PubMedGoogle Scholar
  4. 4.
    Orth, D.N., and Nicholson, W.E., 1977, Different molecular forms of ACTH, Ann. N.Y. Acad. Sci. 297: 27–48.Google Scholar
  5. 5.
    Orth, D.N., and Nicholson, W.W., 1977, High molecular weight forms of human ACTH are glycoproteins, J. Clin. Endocrinol. Metab. 44: 214–217.PubMedGoogle Scholar
  6. 6.
    Gewirtz, G., Schneider, B., Krieger, D.T., and Yalow, R.S., 1974, Big ACTH: Conversion to biologically active ACTH by trypsin, J. Clin. Endocrinol. Metab. 38: 227–230.PubMedGoogle Scholar
  7. 7.
    Eipper, B.A., and Mains, R.E., 1975, High molecular weight forms of adrenocorticotropic hormone in the mouse pituitary and in a mouse pituitary cell line, Biochemistry 14: 3836–3844.PubMedGoogle Scholar
  8. 8.
    Mains, R.E., and Eipper, B.A., 1976, Biosynthesis of adrenocorticotropic hormone in mouse pituitary tumor cells, J. Biol. Chem. 251: 4115–4120.PubMedGoogle Scholar
  9. 9.
    Roberts, J.L., and Herbert, E., 1977, Characterization of a common precursor to corticotropin and β-lipoprotein: Cell free synthesis of the precursor and identification of corticotropin peptides in the molecule, Proc. Natl. Acad. Sci. U.S.A. 74: 4826–4830.PubMedGoogle Scholar
  10. 10.
    Nakanishi, S., Taii, S., Hirata, Y., Matsukura, S., Imura, H., and Numa, S., 1976, A large product of cell-free translation of messenger RNA coding for corticotropin, Proc. Natl. Acad. Sci. U.S.A. 73: 4319–4323.PubMedGoogle Scholar
  11. 11.
    Lee, T.H., and Lee, M.S., 1977, Purification and characterization of high molecular weight forms of adrenocorticotropic hormone of ovine pituitary glands, Biochemistry 16: 2824–2829.PubMedGoogle Scholar
  12. 12.
    Eipper, B.A., Mains, R.E., and Guenzi, D., 1976, High molecular weight forms of adrenocorticotropin hormone are glycoproteins, J. Biol. Chem. 251: 4121–4126.PubMedGoogle Scholar
  13. 13.
    Lowry, P.J., Silman, R.E., and Hope, J., 1977, Structure and biosynthesis of peptides related to corticotropins and β-melanotropins, Ann. N.Y. Acad. Sci. 297: 49–62.PubMedGoogle Scholar
  14. 14.
    Moriarity, G.C., 1973, Adenohypophysis: Ultrastructural chemistry: A review, J. Histochem. Cytochem. 21: 855–894.Google Scholar
  15. 15.
    Pelletier, G., Leclerc, R., Labrie, F., Cote, J., Chretien, M., and Lis, M., 1977, Immunohistochemical localization of β-lipotropic hormone in the pituitary gland, Endocrinology 100: 770–776.PubMedGoogle Scholar
  16. 16.
    Golstein, A., Cox, B.M., Gentleman, S., Lowney, L.I., and Cheung, A.L., 1977, Pituitary and brain opioid peptides (endorphins), Ann. N.Y. Acad. Sci. 297: 108–114.Google Scholar
  17. 17.
    Guillemin, R., Ling, N., Lazarus, L., Burgus, R., Minick, S., Bloom, F., Nicoll, R., Siggins, G., and Segal, D., 1977, The endorphins, novel peptides of brain and hypophysial origin, with opiate-like activity: Biochemical and biologic studies, Ann. N.Y. Acad. Sci. 297: 131–156.PubMedGoogle Scholar
  18. 18.
    Rubinstein, M., Stein, S., Gerber, L., and Undenfriend, S., 1977, Isolation and characterization of the opioid peptides from rat pituitary β-lipotropin, Proc. Natl. Acad. Sci. U.S.A. 74: 3052–3055.PubMedGoogle Scholar
  19. 19.
    Mains, R.E., Eipper, B.A., and Ling, N., 1977, Common precursor to corticotropins and endorphins, Proc. Natl. Acad. Sci. U.S.A. 74: 3014–3018.PubMedGoogle Scholar
  20. 20.
    Jones, R.E., Pulkrabek, P., and Grunberger, D., 1977, Mouse pituitary tumor mRNA directed cell-free synthesis of polypeptides that are cross reactive with adrenocorticotropic hormone antiserum, Biochem. Biophys. Res. Commun. 74: 1490–1495.PubMedGoogle Scholar
  21. 21.
    Eipper, B.A., and Mains, R.E., 1977, Peptide analysis of a glycoprotein form of adrenocorticotropic hormone, J. Biol. Chem. 252: 8821–8832.PubMedGoogle Scholar
  22. 22.
    Liddle, G.W., Island, D., and Meador, C.K., 1962, Normal and abnormal regulation of corticotropin secretion in man, Recent Prog. Horm. Res. 18: 125–166.Google Scholar
  23. 23.
    Krieger, D., Amorosa, L., and Linick, F., 1975, Cyproheptadine-induced remission of Cushing’s disease, N. Engl. J. Med. 293: 893–896.PubMedGoogle Scholar
  24. 24.
    Krieger, D.T., Liotta, A., Suda, T., Palkovits, M., and Brownstein, M.D., 1977, Presence of immunoassayable β-lipotropin in bovine brain and spinal cord: Lack of concordance with ACTH concentrations, Biochem. Biophys. Res. Commun. 76(3): 930–936.PubMedGoogle Scholar
  25. 25.
    Krieger, D.T., Liotta, A., and Brownstein, M.J., 1977, Presence of corticotropin in brain of normal and hypophysectomized rats, Proc. Natl. Acad. Sci. U.S.A. 74(2): 648–652.PubMedGoogle Scholar
  26. 26.
    Sayers, G., 1977, Nature of corticotropin releasing factor, Fed. Proc. Fed. Am. Soc. Exp. Biol. 36: 2087.Google Scholar
  27. 27.
    Brodish, A., 1977, Tissue corticotropin releasing factor, Fed. Proc. Fed. Am. Soc. Exp. Biol. 36: 2088–2093.Google Scholar
  28. 28.
    Vale, W., and River, C., 1977, Substances modulating the secretion of ACTH by cultured anterior pituitary cells, Fed. Proc. Fed. Am. Soc. Exp. Biol. 36: 2094–2099.Google Scholar
  29. 29.
    Seelig, S., and Sayers, G., 1977, Bovine hypothalamic corticotropin releasing factor: Chemical and biological characteristics, Fed. Proc. Fed. Am. Soc. Exp. Biol. 36: 2100–2103.Google Scholar
  30. 30.
    Jones, M.T., Gellham, B., and Hillhouse E.W., 1977, The nature of corticotropin releasing factor from rat hypothalamus in vitro, Fed. Proc. Fed. Am. Soc. Exp. Biol. 36: 2104–2109.Google Scholar
  31. 31.
    Ganong, W.F., 1977, Neurotransmitters involved in ACTH secretion: Catecholamines, Ann. N.Y. Acad. Sci. 297: 509–517.PubMedGoogle Scholar
  32. 32.
    Jones, M.T., and Hillhouse, E.W., 1977, Neurotransmitter regulation of corticotropin-releasing factor in vitro, Ann. N.Y. Acad. Sci. 297: 536–558.PubMedGoogle Scholar
  33. 33.
    Vernikos-Danellis, J., Kellar, K.J., Kent, D., Gonzales, C., Berger, P.A., and Barchas, J.D., 1977, Serotonin involvement in pituitary-adrenal function, Ann. N.Y. Acad. Sci. 297: 518–526.PubMedGoogle Scholar
  34. 34.
    Krieger, D.T., 1977, Serotonin regulation of ACTH secretion, Ann. N.Y. Acad. Sci. 297: 527–535.PubMedGoogle Scholar
  35. 35.
    Fischer, J.L., and Moriarty, M., 1977, Control of bioactine corticotropin release from the neurointermediate lobe of the rat pituitary in vitro, Endocrinology 100: 1047–1054.PubMedGoogle Scholar
  36. 36.
    Krieger, D.T., 1977, Regulation of circadian periodicity of plasma ACTH levels, Ann. N.Y. Acad. Sci. 297: 561–567.PubMedGoogle Scholar
  37. 37.
    Seiden, G., and Brodish, A., 1972, Persistence of a diurnal rhythm in hypothalamic corticotropin-releasing factor (CRF) in the absence of hormone feedback, Endocrinology 90: 1401–1403.PubMedGoogle Scholar
  38. 38.
    Ixart, G., Szafarczyk, A., Belugou, J.L., and Assenmacher, I., 1977, Temporal relationships between the diurnal rhythm of hypothalamic corticotropin releasing factor, pituitary corticotrophin and plasma corticosterone in the rat, J. Endocrinol. 72: 113–120.PubMedGoogle Scholar
  39. 39.
    Dallman, M.F., and Yates, F.E., 1969, Dynamic asymmetries in the corticosteroid feedback path and distribution-metabolism-binding elements of the adrenocortical system, Ann. N.Y. Acad. Sci. 156: 696–721.PubMedGoogle Scholar
  40. 40.
    Jones, M.T., Tiptaft, E.M., Brush, F.R., Fergusson, D.A.N., and Neame, L.B., 1974, Evidence for dual corticosteroid-receptor mechanisms in the feedback control of adrenocorticotrophin secretion, J. Endocrinol. 60: 223–233.PubMedGoogle Scholar
  41. 41.
    Kendall, J.W., Scott, A.K., Allen, C., and Greer, M.A., 1966, Evidence for ACTH secretion and ACTH suppressibility in hypophysectomized rats with multiple heterotopic pituitaries, Endocrinology 78: 533–537.PubMedGoogle Scholar
  42. 42.
    Sayers, G., and Portanova, P., 1974, Secretion of ACTH by isolated anterior pituitary cells: Kinetics of simulation by corticotropin releasing factor and of inhibition by corticosterone, Endocrinology 94: 1723–1730.PubMedGoogle Scholar
  43. 43.
    Mims, R.B., 1973, Plasma ACTH in the adrenalectomized rat, Horm. Metab. Res. 5: 368–371.PubMedGoogle Scholar
  44. 44.
    Rees, L.H., Cook, D.M., Kendall, J.W., Allen, C.F., Kramer, R.M., Ratcliff, J.G., and Knight, R.A., 1971, A radioimmunoassay for rat plasma ACTH, Endocrinology 89: 254–261.PubMedGoogle Scholar
  45. 45.
    Nakanishi, S., Kita, T., Taii, S., Imura, H., and Numa, S., 1977, Glucocorticoid effect on the level of corticotropin messenger RNA activity in rat pituitary, Proc. Natl. Acad. Sci. U.S.A. 74: 3283–3286.PubMedGoogle Scholar
  46. 46.
    O’Malley, B.W., and Buller, R.E., 1976, Current concepts in steroid hormone action, in: The Year in Endocrinology 1975–1976 (S.H. Ingbar, ed.), pp. 277–315, Plenum Medical Book Company, New York.Google Scholar
  47. 47.
    Arimura, A., Bowers, C.Y., Schally, A.V., Saito, M., and Miller, M.C., III, 1969, Effect of corticotropin-releasing factor, dexamethasone and actinomycin D on the release of ACTH from rat pituitaries in vivo and in vitro, Endocrinology 85: 300–311.PubMedGoogle Scholar
  48. 48.
    Portanova, R., and Sayers, G., 1974, Corticosterone suppression of ACTH secretion: Actinomycin D sensitive and insensitive components of the response, Biochem. Biophys. Res. Commun. 56: 928–933.PubMedGoogle Scholar
  49. 49.
    Brattin, W.J., and Portanova, R., 1977, Corticosterone induction of pituitary hyperresponsiveness to CRF: Divergent effects of puromycin and cycloheximide, Mol. Cell. Endocrinol. 7: 221–231.PubMedGoogle Scholar
  50. 50.
    Mulder, G.H., and Smelik, P.G., 1977, A superfusion system technique for the study of the sites of action of glucocorticoids in the rat hypothalamus-pituitary-adrenal system in vitro. I. Pituitary cell superfusion, Endocrinology 100: 1143–1152.Google Scholar
  51. 51.
    Vermes, I., Mulder, G.H., and Smelik, P.G., 1977, A superfusion system technique for the study of the sites of action of glucocorticoids in the rat hypothalamic-pituitary-adrenal system in vitro. II. Hypothalamus-pituitary cell-adrenal cell superfusion, Endocrinology 100: 1153–1159.PubMedGoogle Scholar
  52. 52.
    Abe, K., and Critchlow, V., 1977, Effects of corticosterone, dexamethasone and surgical isolation of the medial basal hypothalamus on rapid feedback control of stress-induced corticotrophin secretion in female rats, Endocrinology 101: 498–505.PubMedGoogle Scholar
  53. 53.
    Jones, M.T., and Tiptaft, E.M., 1977, Structure-activity relationship of various corticosteroids on the feedback control of corticotrophin secretion, Br. J. Pharmacol. 59: 35–41.PubMedGoogle Scholar
  54. 54.
    Herbert, E., Allen, R.G., and Paquette, T.L., 1978, Reversal of dexamethasone inhibition of adrenocorticotropin release in a mouse pituitary tumor cell line either by growing cells in the absence of dexamethasone or by addition of hypothalamic extract, Endocrinology 102: 218–226.PubMedGoogle Scholar
  55. 55.
    Watanabe, H., Nicholson, W., and Orth, D., 1973, Inhibition of adrenocorticotropic hormone production by glucocorticoids in mouse pituitary tumor cells, Endocrinology 93: 411–416.PubMedGoogle Scholar
  56. 56.
    Richardson, U.I., 1978, Self-regulation of adrenocorticotropin secretion by mouse pituitary tumor cells in cudture, Endocrinology 102: 910–917.PubMedGoogle Scholar
  57. 57.
    Kan, K.W., Baird, A., Seidah, N.G., Lis, M., Chretien, M., Ling, N., Guillemin, R., and Solomon, S., 1977, Effects of peptides of pituitary origin on the formation of C21 steroid by fetal calf adrenal cells in culture, Biochem. Biophys. Res. Commun. 79: 553–560.PubMedGoogle Scholar
  58. 58.
    Holaday, J.W., Law, P.Y., Tseng, L.F., Loh, H.H., and Li, C.H., 1977, β-Endorphin: Pituitary and adrenal glands modulate its action, Proc. Natl. Acad. Sci. U.S.A. 74: 4628–4632.PubMedGoogle Scholar
  59. 59.
    Guillemin, R., Vargo, T., Rossier, J., Minick, S., Ling, N., Rivier, C., Vale, W., and Bloom, F., 1977, β-Endorphin and adrenocorticotropin are secreted concomitandy by the pituitary gland, Science 197: 1367–1369.PubMedGoogle Scholar
  60. 60.
    Tanaka, K., Nicholson, W.E., and Orth, D.N., 1978, Diurnal rhythm and disappearance half-time of endogeneous plasma immunoreactive β-MSH (LPH) and ACTH in man, J. Clin. Endocrinol. Metab. 46: 883–890.PubMedGoogle Scholar
  61. 61.
    Abe, K., Nicholson, W.E., Iiddle, G.W., Island, D.D., and Orth, D.N., 1967, Radioimmunoassay of β-MSH in human plasma and tissues, J. Clin. Invest 46: 1609–1616.PubMedGoogle Scholar
  62. 62.
    Abe, K., Nicholson, W.E., Iiddle, G.W., Orth, D.N., and Island, D.P., 1969, Normal and abnormal regulation of β-MSH in man, J. Clin. Invest. 48: 1580–1585.PubMedGoogle Scholar
  63. 63.
    Sabol, S.L., 1978, Regulation of endorphin production by glucocorticoids in cultured pituitary tumor cells, Biochem. Biophys. Res. Commun. 82: 560–567.PubMedGoogle Scholar
  64. 64.
    Besser, G.M., Orth, D.N., Nicholson, W.E., Byyny, R.L., Abe, K., and Woodham, J.P., 1971, Dissociation of the disappearance of bioactive and radioimmunoreactive ACTH from plasma in man, J. Clin. Endocrinol. Metab. 32: 595–603.PubMedGoogle Scholar
  65. 65.
    Meakin, J.W., Tingey, W.H., Jr., and Nelson, D.H., 1960, The catabolism of adrenocorticotropic hormone: The stability of adrenocorticotropic hormone in blood, plasma, serum and saline, Endocrinology 66: 59–72.PubMedGoogle Scholar
  66. 66.
    McMartin, C., and Peters, J., 1975, Levels of corticotrophin analogues in the blood after infusion into rats, J. Endocrinol. 67: 41–48.PubMedGoogle Scholar
  67. 67.
    Baker, J.R.J., Bennett, H.P.J., Hudson, A.M., McMartin, C., and Purdon, G.E., 1976, On the metabolism of two adrenocorticotrophin analogues, Clin. Endocrinol. 5 (Suppl.), pp. 61s–72s.Google Scholar
  68. 68.
    Keenan, J., Thompson, J.B., Chamberlain, M.A., and Besser, G.M., 1971, Prolonged corticotrophic action of a synthetic substituted 1–18ACTH, Br. Med. J. 3: 742–743.PubMedGoogle Scholar
  69. 69.
    Baker, J.R.J., Bennett, H.P.J., Christian, R.A., and McMartin, C., 1977, Renal uptake and metabolism of adrenocorticotropin analogues in the rat: An autoradiographic study, J. Endocrinol. 74: 23–35.PubMedGoogle Scholar
  70. 70.
    Varandani, P.T., and Shroyer, L.A., 1977, A rat kidney neutral peptidase that degrades B chain of insulin, glucagon, and ACTH: Purification by affinity chromatography and some properties, Arch. Biochem. Biophys. 181: 82–93.PubMedGoogle Scholar
  71. 71.
    Jeffcoate, W.J., Phenekos, C., Ratcliffe, J.G., Williams, S., Rees, L., and Besser, G.M., 1977, Comparison of the pharmacokinetics in man of two synthetic ACTH analogues: α1–24 and substituted α1–18 ACTH, Clin. Endocrinol. 7: 1–11.Google Scholar
  72. 72.
    McMartin, C., Purdon, G.E.E., Schenkel, L., Desaulles, P., Maier, R., Brugger, M., Rittel, W., and Sieber, P., 1977, Differences between in-vitro and in-vivo potencies of corticotrophins: An interpretation in terms of metabolic stability, J. Endocrinol. 73: 79–89.PubMedGoogle Scholar
  73. 73.
    Van Nispen, J.W., Tesser, G.I., Barthe, P.L., Maier, R., and Schenkel-Hulliger, L., 1977, Biological activities of ACTH analogues varied in the active site, Acta Endocrinol. 84: 470–484.PubMedGoogle Scholar
  74. 74.
    Finn, F., Johns, P., Nishi, N., and Hofman, K., 1976, Differential response to adrenocorticotropin hormone analogs of bovine adrenal plasma membrane and cells, J. Biol. Chem. 251: 3576–3585.PubMedGoogle Scholar
  75. 75.
    Hofman, K., Andreatta, R., Bohn, K., and Morodor, L., 1970, Studies on polypeptides. XLV. Structure function studies in the β-corticotropin series, J. Med. Chem. 13: 339–345.Google Scholar
  76. 76.
    Garren, L.D., Ney, R.L., and Davis, W.W., 1965, Studies on the role of protein synthesis in the regulation of corticosterone production by adrenocorticotropic hormone in vivo, Proc. Natl. Acad. Sci. U.S.A. 53: 1443–1450.PubMedGoogle Scholar
  77. 77.
    Beall, R.J., and Sayers, G., 1972, Isolated adrenal cells: Steroidogenesis and cyclic AMP accumulation in response to ACTH, Arch. Biochem. Biophys. 148: 70–76.PubMedGoogle Scholar
  78. 78.
    Moyle, W.R., Kong, Y.C., and Ramachandran, J., 1973, Steroidogenesis and cyclic adenosine 3′,5′-monophosphate accumulation in rat adrenal cell, J. Biol. Chem. 248: 2409–2417.PubMedGoogle Scholar
  79. 79.
    Schimmer, B.P., Tsao, J., and Knapp, M., 1977, Isolation of mutant adrenocortical tumor cells resistant to cyclic nucleotides, Mol. Cell. Endocrinol. 8: 135–145.PubMedGoogle Scholar
  80. 80.
    Riou, J.P., Evain, D., Perrin, F., and Saez, J.M., 1977, Adenosine 3′5′-cyclic monophosphate dependent protein kinase in human adrenocortical tumors, J. Clin. Endocrinol. Metab. 44: 413–419.PubMedGoogle Scholar
  81. 81.
    Hornsby, P.J., and Gill, G.N., 1977, Hormonal control of adrenocortical cell proliferation: Desensitization to ACTH and interaction between ACTH and fibroblast growth factor in bovine adrenocortical cell cultures, J. Clin. Invest. 60: 342–352.PubMedGoogle Scholar
  82. 82.
    Hornsby, P.J., and Gill, G.N., 1978, Characterization of adult bovine adrenocortical cells throughout their life span in tissue culture, Endocrinology 102: 926–936.PubMedGoogle Scholar
  83. 83.
    Rubin, R.P., Laychock, S.G., and End, D.W., 1977, On the role of cyclic AMP and cyclic GMP in steroid production by bovine cortical cells, Biochem. Biophys. Acta 496: 329–338.PubMedGoogle Scholar
  84. 84.
    Perchellet, J.P., Shanker, G., and Sharma, R.K., 1978, Regulatory role of guanosine 3′,5′-monophosphate in adrenocorticotropin hormone-induced steroidogenesis, Science 199: 311–312.PubMedGoogle Scholar
  85. 85.
    Honn, K.V., and Chavin, W., 1977, In vitro temporal cAMP and cortisol responses to ACTH by the normal human adrenal gland, Acta Endocrinol. 85: 823–831.PubMedGoogle Scholar
  86. 86.
    Schlegel, W., and Schwyzer, R., 1977, Purification of bovine adrenal-cortex plasma-membrane vesicles containing a highly corticotropin-sensitive adenylate-cyclase system and angiotensin-II-binding sites, Eur. J. Biochem. 72: 415–424.PubMedGoogle Scholar
  87. 87.
    Rodbell, M., Birnbaumer, L., Pohl, S.L., and Krans, M.J., 1971, The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. V. An obligatory role of guanyl nucleotides in glucagon action, J. Biol. Chem. 246: 1877–1882.PubMedGoogle Scholar
  88. 88.
    Glynn, P., Cooper, D.M.F., and Schulster, D., 1977, Control of bovine adrenocortical adenylate cyclase activity by guanine nucleotides, Biochem. Soc. Trans. 5: 973–975.PubMedGoogle Scholar
  89. 89.
    Rodbell, M., Lin, M.C., Salomon, Y., Londos, C., Harwood, J.P., Martin, B.R., Rendell, M., and Berman, M., 1975, Role of adenine and guanine nucleotides in the activity and response of adenylate cyclase systems to hormones: Evidence for multisite transition states, Adv. Cyclic Nucleotide Res. 5: 3–29.PubMedGoogle Scholar
  90. 90.
    Bonnafous, J.C., Fauchere, J.L., Schlegel, W., and Schwyzer, R., 1977, Hormone-receptor interactions: Stimulation and inhibition of bovine adrenal cortex cell membrane adenylate cyclase by synthetic corticotropin fragments and the effect of 5′-guanylylimidodiphosphate, FEBS Lett. 78: 247–250.PubMedGoogle Scholar
  91. 91.
    Glossman, H., and Struck, C.J., 1977, Adrenal cortex adenylate cyclase: In vitro modification of the enzyme by cholera toxin, Naunyn-Schmiedeberg’s Arch. Pharmacol. 299: 175–185.Google Scholar
  92. 92.
    Mahaffee, D., Reitz, R.C., and Ney, R.I., 1974, The mechanism of action of adrenocorticotropic hormone: The role of mitochondrial cholesterol accumulation in the regulation of steroidogenesis, J. Biol. Chem. 249: 227–233.PubMedGoogle Scholar
  93. 93.
    Paul, D.P., Gallant, S., Orime-Johnson, J.R., and Brownie, A.C., 1976, Temperature dependence of cholesterol binding to cytochrome P-450SCC of the rat adrenal: Effect of corticotropic hormone and cycloheximide, J. Biol. Chem. 251: 7120–7126.PubMedGoogle Scholar
  94. 94.
    Tilley, B.E., Watanuki, M., and Hall, P.F., 1977, Preparation and properties of side-chain cleavage cytochrome P-450 from bovine adrenal cortex by affinity chromatography with pregnenolone as ligand, Biochim. Biophys. Acta 493: 260–271.PubMedGoogle Scholar
  95. 95.
    Watanuki, M., Tilley, B.E., and Hall, P.F., 1977, Purification and properties of cytochrome P-450 (11β-and 18-hydroxylase) from bovine adrenocortical mitochondria, Biochem. Biophys. Acta 483: 236–427.PubMedGoogle Scholar
  96. 96.
    Wang, H.P., and Kimura, T., 1976, Purification and characterization of adrenal cortex mitochondrial cytochrome P-450 specific for cholesterol side chain cleavage activity, J. Bid. Chem. 251: 6068–6074.Google Scholar
  97. 97.
    Shikita, M., and Hall, P.F., 1973, Cytochrome P-450 from bovine adrenocortical mitochondria: An enzyme for the side chain cleavage of cholesterol. I. Purification and properties, J. Biol. Chem. 248: 5598–5604.PubMedGoogle Scholar
  98. 98.
    Tilley, B.E., Watanuki, M., and Hall, P.F., 1977, Side-chain cleavage P-450 from bovine adrenocortical mitochondria: Reconstitution of enzyme activity, Biochem. Biophys. Acta 488: 330–339.PubMedGoogle Scholar
  99. 99.
    Watanuki, M., Granger, G.A., and Hall, P.F., 1978, Cytochrome P-450 from bovine adrenocortical mitochondria. Immunochemical properties and purity, J. Biol. Chem. 253: 2927–2931.PubMedGoogle Scholar
  100. 100.
    Jefcoate, C.R., 1977, Cytochrome P-450 of adrenal mitochondria: Steroid binding sites on two distinguishable forms of rat adrenal mitochondrial cytochrome P-450SCC, J. Biol Chem. 252: 8788–8796.PubMedGoogle Scholar
  101. 101.
    Björkhem, I., and Karlmar, K.E., 1977, Common characteristics of the cytochrome P-450 system involved in 18-and 11β-hydroxylation of deoxycorticosterone in rat adrenals, J. Lipid Res. 18: 592–603.PubMedGoogle Scholar
  102. 102.
    Moustafa, A.M., and Koritz, S.B., 1977, Studies on the stimulation by Ca2+ and the inhibition by ADP of steroid 11β-hydroxylation in adrenal mitochondria, Eur. J. Biochem. 78: 231–238.PubMedGoogle Scholar
  103. 103.
    Simpson, E.R., McCarthy, J.L., and Peterson, J.A., 1978, Evidence that the cydoheximide sensitive site of adrenocorticotropic hormone action is in the mitochondrion, J. Biol. Chem. 253: 3135–3139.PubMedGoogle Scholar
  104. 104.
    Farese, R.V., and Prudente, W.J., 1977, On the requirement for protein synthesis during corticotropin-induced stimulation of cholesterol side chain cleavage in rat adrenal mitochondrial and solubilized desmolase preparations, Biochim. Biophys. Acta 496: 567–570.PubMedGoogle Scholar
  105. 105.
    Koritz, S.B., and Kumar, A.M., 1970, On the mechanism of action of the adrenocorticotrophic hormone. The stimulation of the activity of enzymes involved in pregnenolone synthesis, J. Biol. Chem. 245: 152–159.PubMedGoogle Scholar
  106. 106.
    Andersen, J.M., and Dietschy, J.M., 1976, Regulation of sterol synthesis in adrenal gland of the rat by both high and low density human plasma lipoproteins, Biochem. Biophys. Res. Commun. 72: 880–885.PubMedGoogle Scholar
  107. 107.
    Andersen, J.M., and Dietschy, J.M., 1977, Regulation of sterol synthesis in 16 tissues of rat. I. Effect of diurnal light cycling, fasting, stress, manipulation of enterohapatic circulation and administration of chylomicrons and triton, J. Biol. Chem. 252: 3646–3651.PubMedGoogle Scholar
  108. 108.
    Andersen, J.M., and Dietschy, J.M., 1977, Regulation of sterol synthesis in 15 tissues of rat. II. Role of rat and human high and low density plasma lipoproteine and of rat chylomicrons remnants, J. Biol. Chem. 252: 3652–3659.PubMedGoogle Scholar
  109. 109.
    Balasubramaniam, S., Goldstein, J.L., Faust, J.R., Brunschede, G.Y., and Brown, M.S., 1977, Lipoprotein-mediated regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesteryl ester metabolism in the adrenal gland of the rat, J. Biol. Chem. 252: 1771–1779.PubMedGoogle Scholar
  110. 110.
    Balasubramanian, S., Goldstein, J.L., and Brown, M.S., 1977, Regulation of cholesterol synthesis in rat adrenal gland through coordinate control of 3-hydroxy-3-methylglutaryl coenzyme A synthase and reductase activities. Proc. Natl Acad. Sci. U.S.A. 74: 1421–1425.Google Scholar
  111. 111.
    Brecher, P.I., and Hyun, Y., 1978, Effect of 4-aminopyrazolopyrimidine and aminoglutethimide on cholesterol metabolism and steroidogenesis in the rat adrenal, Endocrinology 102: 1404–1413.PubMedGoogle Scholar
  112. 112.
    Gwynne, J.T., and Hess, B., 1979, Role of high density lipoproteins in rat adrenal steroidogenesis and cholesterol metabolism (submitted).Google Scholar
  113. 113.
    Gwynne, J.T., and Hess, B., 1978, Binding and degradation of human 12I-HDL by rat adrenocortical cells, Metabolism 27: 1593–1600.PubMedGoogle Scholar
  114. 114.
    Gwynne, J.T., Hughes, T., Roundtree, R., and Hess, B., 1979, Properties and ACTH regulation of the HDL receptors of the rat adrenal cortex (submitted).Google Scholar
  115. 115.
    Faust, J.R., Goldstein, J.L., and Brown, M.S., 1977, Receptor-mediated uptake of low density lipoprotein and utilization of its cholesterol for steroid synthesis in cultured mouse adrenal cells, J. Biol. Chem. 252: 4861–4871.PubMedGoogle Scholar
  116. 116.
    Brown, M.S., and Goldstein, J.L., 1976, Receptor mediated control of cholesterol metabolism, Science 191: 150–154.PubMedGoogle Scholar
  117. 117.
    Naghshineh, S., Treadwell, C.R., Gallo, L., and Vahouny, G.V., 1974, Activation of adrenal steroid ester-hydroylase by dibutyryl cAMP and protein kinase, Biochem. Biophys. Res. Commun. 61: 1076–1082.PubMedGoogle Scholar
  118. 118.
    Trzeciak, W.H., and Boyd, G.S., 1974, Activation of cholesteryl esterase in bovine adrenal cortex, Eur. J. Biochem. 46: 201–207.PubMedGoogle Scholar
  119. 119.
    Beckett, G.J., and Boyd, G.S., 1977, Purification and control of bovine adrenal cortical cholesterol ester hydrolase and evidence for the activation of the enzyme by a phosphorylation, Eur. J. Biochem. 72: 223–233.PubMedGoogle Scholar
  120. 120.
    Cortese, F., and Wolff, J., 1978, Cytochalasin-stimulated steroidogenesis from high density lipoproteins, J. Cell. Biol. 77: 507–516.PubMedGoogle Scholar
  121. 121.
    Mrotek, J.J., and Hall, P.F., 1975, The influence of cytochalasin B on the response of adrenal tumor cells to ACTH and cyclic AMP, Biochem. Biophys. Res. Commun. 64: 891–896.PubMedGoogle Scholar
  122. 122.
    Mrotek, J.J., and Hall, P.F., 1977, Response of adrenal tumor cells to adrenocorticotropin: Site of inhibition by cytochalasin B, Biochemistry 16: 3177–3181.PubMedGoogle Scholar
  123. 123.
    Hadjian, A.J., Guidicelli, C., and Chambaz, E.M., 1977, Characterization of tubulin in the bovine adrenal cortex cytosol, FEBS Lett. 77: 233–238.PubMedGoogle Scholar
  124. 124.
    Strott, C.A., and Ray, P., 1977, Studies of a colchicine-binding protein (tubulin) in the adrenal cortex and brain, Biochim. Biophys. Acta 495: 119–128.PubMedGoogle Scholar
  125. 125.
    Temple, R., and Wolff, J., 1973, Stimulation of steroid secretion by antimicrotubular agents, J. Biol. Chem. 248: 2691–2698.PubMedGoogle Scholar
  126. 126.
    O’Hare, M.J., 1976, Monolayer cultures of normal adult rat adrenocortical cells: Steroidogenic responses to nucleotides, bacterial toxins and antimicrotubular agents, Experientia 32: 251–253.PubMedGoogle Scholar
  127. 127.
    Liddle, G.W., 1960, Tests of pituitary adrenal suppressibility in the diagnosis of Cushing’s syndrome, J. Clin. Endocrinol. Metab. 20: 1539–1560.PubMedGoogle Scholar
  128. 128.
    Liddle, G.W., Estep, H.L., Kendall, J.W., Williams, W.C., Jr., and Townes A.W., 1959, Clinical application of a new test of pituitary reserve, J. Clin. Endocrinol. Metab. 19: 875–894.PubMedGoogle Scholar
  129. 129.
    Besser, G.M., 1973, ACTH and MSH assays and their clinical application, Clin. Endocrinol. 2: 175–186.Google Scholar
  130. 130.
    Similä, S., Kauppila, A., Ylikorkala, O., Koivisto, M., Mäkelä, P., and Haapalahti, J., 1977, Adrenocorticotrophic hormone during the first day of life, Eur. J. Pediatr. 124: 173–177.PubMedGoogle Scholar
  131. 131.
    Winters, A.J., Oliver, C., Colston, C., MacDonald, P.C., and Porter, J.C., 1974, Plasma ACTH levels in the human fetus and neonate as related to age and parturition, J. Clin. Endocrinol. Metab. 39: 269–273.PubMedGoogle Scholar
  132. 132.
    Berson, S.A., and Yalow, R.S., 1968, Radioimmunoassay of ACTH in plasma, J. Clin. Invest. 47: 2725–2751.PubMedGoogle Scholar
  133. 133.
    Miyakawa, I., Ikeda, I., and Maeyama, M., 1974, Transport of ACTH across human placenta, J. Clin. Endocrinol. Metab. 39: 440–442.PubMedGoogle Scholar
  134. 134.
    Allen, J.P., Cook, D.M., Kendall, J.W., and McGilvra, R., 1973, Maternal-fetal ACTH relationship in man, J. Clin. Endocrinol. 37: 230–234.Google Scholar
  135. 135.
    Liotta, A., Osathanondh, R., Ryan, K.J., and Krieger, D.T., 1977, Presence of corticotropin in human placenta: Demonstration of in vivo synthesis, Endocrinology 101: 1552–1558.PubMedGoogle Scholar
  136. 136.
    Kauppila, A., Similä, S., Ylikorkala, O., Koivisto, M., Mäkelä, P., and Haapalahti, J., 1976, ACTH levels in maternal, fetal and neonatal plasma, after short term prenatal dexamethasone therapy, Br. J. Obstet. Gynecol. 84: 124–128.Google Scholar
  137. 137.
    Schmidt, I.G., and Hoffman, R.G., 1954, Effects of ACTH on pregnant monkeys and their offspring, Anat. Rec. 118: 351–352.Google Scholar
  138. 138.
    West, C.D., and Dolman, L.I., 1977, Plasma ACTH radioimmunoassay in the diagnosis of pituitary-adrenal dysfunction, Ann. N.Y. Acad. Sci. 297: 205–219.PubMedGoogle Scholar
  139. 139.
    Jubiz, W., Meikle, A.W., West, C.D., and Tyler, F.H., 1970, Single-dose metyrapone test, Arch. Intern. Med. 125: 472–474.PubMedGoogle Scholar
  140. 140.
    Schoneshofer, M., L’age, M., and Oelkers, N., 1977, Short time kinetics of deoxycorticosterone, deoxycortisol, corticosterone and cortisol during single dose metyrapone test, Acta Endocrinol. 85: 109–117.PubMedGoogle Scholar
  141. 141.
    Nishida, S., Matsumura, S., Horino, M., Oyama, H., and Tenku, A., 1977, The variations of plasma corticosterone/cortisol ratios following ACTH stimulation or dexamethasone administration in normal men, J. Clin. Endocrinol. Metab. 45: 585–588.PubMedGoogle Scholar
  142. 142.
    Kolanowski, J., Esselinckx, W., Nagant, C., and Crabbe, J., 1977, Adrenocortical response upon repeated stimulation with corticotrophin in patients lacking endogenous corticotrophin secretion, Acta Endocrinol. 85: 595–607.PubMedGoogle Scholar
  143. 143.
    Besser, G., and Landon, J., 1968, Plasma levels of immunoreactive corticotrophin in patients with Cushing’s syndrome, Br. Med. J. 4: 552–554.PubMedGoogle Scholar
  144. 144.
    Gilkes, J.J.H., Rees, L.H., and Besser, G.M., 1977, Plasma immunoreactive corticotrophin and lipotrophin in Cushing’s syndrome and Addison’s disease, Br. Med. J. 1: 996–998.PubMedGoogle Scholar
  145. 145.
    Hankin, M.E., Theile, H.M., and Steinbeck, A.W., 1977, An evaluation of laboratory tests for the detection and differential diagnosis of Cushing’s syndrome, Clin. Endocrinol. 6: 185–196.Google Scholar
  146. 146.
    Perlstein, R., Kopp, L., and Tucci, J.R., 1977, The effect of pituitary adrenal manipulations upon urinary cyclic AMP excretion in man, Acta Endocrinol. 84: 343–348.PubMedGoogle Scholar
  147. 147.
    Cushing, H., 1932, The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism), Bull. Johns Hopkins Hosp. 50: 137–195.Google Scholar
  148. 148.
    Plotz, C.M., Knowlton, A.I., and Ragan, C., 1952, The natural history of Cushing’s syndrome, Am. J. Med. 13: 597–614.PubMedGoogle Scholar
  149. 149.
    Tyrrell, J.B., Brooks, R.M., Fitzgerald, P.A., Cofoid, P.B., Forsham, P.H., and Wilson, C.B., 1978, Cushing’s disease: Selective trans-sphenoidal resection of pituitary microadenomas, N. Engl. J. Med. 298: 753–758.PubMedGoogle Scholar
  150. 150.
    Salassa, R.M., Laws, E.R., Carpenter, P.C., and Northcutt, R.C., 1978, Transphenoidal removal of pituitary microadenoma in Cushing’s disease, Mayo Clin. Proc. 53: 24–28.PubMedGoogle Scholar
  151. 151.
    Krieger, D.T., Amorosa, L., and Iinick, F., 1975, Cyproheptadine-induced remission of Cushing’s disease, N. Engl. J. Med. 293: 893–896.PubMedGoogle Scholar
  152. 152.
    Krieger, D.T., and Condon, E.M., 1978, Cyproheptadine treatment of Nelson’s syndrome: Restoration of plasma ACTH circadian periodicity and reversal of response to TRF, J. Clin. Endocrinol. Metab. 46: 349–351.PubMedGoogle Scholar
  153. 153.
    Krieger, D.T., and Luria, M., 1977, Plasma ACTH and cortisol responses to TRF, vasopressin, or hypoglycemia in Cushing’s disease and Nelson’s syndrome, J. Clin. Endocrinol. Metab. 44: 361–368.PubMedGoogle Scholar
  154. 154.
    Krieger, D., and Glick, S.M., 1972, Growth hormone and cortisol responsiveness in Cushing’s syndrome, Am. J. Med. 52: 25–40.PubMedGoogle Scholar
  155. 155.
    James, V.H.T., Landon, J., Wynn, V., and Greenwood, F.C., 1968, A fundamental defect of adrenocortical control in Cushing’s disease, J. Endocrinol. 40: 15–28.PubMedGoogle Scholar
  156. 156.
    Tyrrell, J.B., Wiener-Kronish, J., Lorenzi, M., Brooks, R.M., and Forsham, P.H., 1977, Cushing’s disease: Growth hormone response to hypoglycemia after correction of hypercortisolism, J. Clin. Endocrinol. Metab. 44: 218–220.PubMedGoogle Scholar
  157. 157.
    Demura, R., Demura, H., Nunokawa, T., Baba, H., and Miura, K., 1972, Responses of plasma ACTH, GH, LH, and 11-hydroxycorticosteroids to various stimuli in patients with Cushing’s syndrome, J. Clin. Endocrinol. Metab. 34: 852–859.PubMedGoogle Scholar
  158. 158.
    Lamberts, S.W.J., Timmermans, H.A.T., de Jong, F.H., and Birkenhager, J.C., 1977, The role of dopaminergic depletion in the pathogenesis of Cushing’s disease and the possible consequences for medical therapy, Clin. Endocrinol. 7: 185–193.Google Scholar
  159. 159.
    Wilber, J.F., and Utiger, R.D., 1969, The effect of glucocorticoids on thyrotropin secretion, J. Clin. Invest. 48: 2096–2103.PubMedGoogle Scholar
  160. 160.
    Smals, A.G.H., Kloppenborg, P.W.C., and Benraad, T.J., 1977, Plasma testosterone profiles in Cushing’s disease, J. Clin. Endocrinol. Metab. 45: 240–245.PubMedGoogle Scholar
  161. 161.
    Luton, J.P., Thieblot, P., Valcke, J.C., Mahoudeau, J.A., and Bricare, H., 1977, Reversible gonadotropin deficiency in male Cushing’s disease, J. Clin. Endocrinol. Metab. 45: 488–495.PubMedGoogle Scholar
  162. 162.
    Boccuzzi, G., Angeli, A., Bisbocci, D., Fonzo, D., Gaidano, G.P., and Ceresa, F., 1975, Effect of synthetic luteinizing hormone releasing hormone (LH-RH) on the release of gonadotropins in Cushing’s disease, J. Clin. Endocrinol. Metab. 40: 892–895.PubMedGoogle Scholar
  163. 163.
    Orth, D.N., and Liddle, G.W., 1971, Results of treatment in 108 patients with Cushing’s syndrome, N. Engl. J. Med. 285: 243–247.PubMedGoogle Scholar
  164. 164.
    Moore, T.J., Dluhy, R.G., Williams, G.H., and Cain, J.P., 1976, Nelson’s syndrome: Frequency, prognosis, and effect of prior pituitary irradiation, Ann. Intern. Med. 85: 731–734.PubMedGoogle Scholar
  165. 165.
    Jennings, A.S., Liddle, G.W., and Orth, D.N., 1977, Results of treating childhood Cushing’s disease with pituitary irradiation, N. Engl. J. Med. 297: 957–962.PubMedGoogle Scholar
  166. 166.
    Scott, H.W., Liddle, G.W., Mulherin, J.L., McKenna, T.J., Stroup, S.L., and Rhamy, R.K., 1977, Surgical experience with Cushing’s disease, Ann. Surg. 185: 524–534.PubMedGoogle Scholar
  167. 167.
    Krieger, D.T., and Luria, M., 1976, Effectiveness of cyproheptadine in decreasing plasma ACTH concentration in Nelson’s syndrome, J. Clin. Endocrinol. Metab. 43: 1179–1181.PubMedGoogle Scholar
  168. 168.
    Hardy, J., 1975, Trans-sphenoidal microsurgical removal of pituitary micro-adenoma, Prog. Neurol. Surg. 6: 200–216.Google Scholar
  169. 169.
    Carmalt, M.H.B., Dalton, G.A., Fletcher, R.F., and Smith, W.T., 1977, The treatment of Cushing’s disease by trans-sphenoidal hypophysectomy, Q.J. Med. 46: 119–134.PubMedGoogle Scholar
  170. 170.
    Daughaday, W.H., 1978, Cushing’s disease and basophilic microadenomas (editorial), N. Engl. J. Med. 298: 793–794.PubMedGoogle Scholar
  171. 171.
    Jeffcoate, W.J., Rees, L.H., Tomlin, S., Jones, A.E., Edwards, C.R.W., and Besser, G.M., 1977, Metyrapone in long-term management of Cushing’s disease, fir. Med. J. 2: 215–217.Google Scholar
  172. 172.
    Orth, D.N., 1978, Metyrapone is useful only as adjunctive therapy in Cushing’s disease, Ann. Intern. Med. 89: 128–130.PubMedGoogle Scholar
  173. 173.
    Zachmann, M., Gitzelmann, R.P., Zagalak, M., and Prader, A., 1977, Effects of aminoglutethimide on urinary cortisol and cortisol metabolites in adolescents with Cushing’s syndrome, Clin. Endocrinol. 7: 63–71.Google Scholar
  174. 174.
    Bartter, F.C., 1977, Adrenogenital syndromes: From physiology to chemistry (1950–1975), in: Congenital Adrenal Hyperplasia (P.A. Lee, L.P. Plotnick, A.A. Kowarski, and C.J. Migeon, eds.), pp. 9–18, University Park Press, Baltimore.Google Scholar
  175. 175.
    Bongiovanni, A.M., and Eberlain, W.R., 1958, Defective steroidal biogenesis in congenital adrenal hyperplasia, Pediatrics 21: 661–672.PubMedGoogle Scholar
  176. 176.
    Kowarski, A., Finkelstein, J.W., Spaulding, J.S., Holman, G.H., and Migeon, C., 1965, Aldosterone secretion rate in congenital adrenal hyperplasia: A discussion of the theories on the pathogenesis of the salt-losing form of the syndrome, J. Clin. Invest. 44: 1505–1513.PubMedGoogle Scholar
  177. 177.
    New, M.I., Miller, B., and Peterson, R.E., 1966, Aldosterone excretion in normal children and in children with adrenal hyperplasia, J. Clin. Invest. 45: 412–428.PubMedGoogle Scholar
  178. 178.
    Kowarski, A.A., 1977, Mechanism of salt losses in congenital virilizing adrenal hyperplasia, in: Congenital Adrenal Hyperplasia (P.A. Lee, L.P. Plotnick, A.A. Kowarski, and C.J. Migeon, eds.), pp. 113–124, University Park Press, Baltimore.Google Scholar
  179. 179.
    Bartter, F.C., Henkin, R.I., and Bryan, G.T., 1968, Aldosterone hypersecretion in “non-salt losing” congenital adrenal hyperplasia, J. Clin. Invest. 47: 1742–1752.PubMedGoogle Scholar
  180. 180.
    Godard, C., Riondel, A., Veyrat, R., Megevand, A., and Muller, A.F., 1968, Plasma renin activity and aldosterone secretion in congenital adrenal hyperplasia, Pediatrics 41: 883–896.PubMedGoogle Scholar
  181. 181.
    Strickland, A.L., and Kotchen, T.A., 1972, A study of the renin-aldosterone system in congenital adrenal hyperplasia, J. Pediatr. 81: 962–969.PubMedGoogle Scholar
  182. 182.
    Hughes, I.A., and Winter, J.S.D., 1977, 17-Hydroxyprogesterone and plasma renin activity in congenital adrenal hyperplasia, in: Congenital Adrenal Hyperplasia (P.A. Lee, L.P. Plotnick, A.A. Kowarski, and C.J. Migeon, eds.), pp. 141–156, University Park Press, Baltimore.Google Scholar
  183. 183.
    Strott, C.A., Yoshimi, T., and Lipsett, M.B., 1969, Plasma progesterone and 17-hydroxyprogesterone in normal men and children with congenital adrenal hyperplasia, J. Clin. Invest. 48: 930–939.PubMedGoogle Scholar
  184. 184.
    Hughes, I.A., and Winter, J.S.D., 1976, The application of a serum 17OH-progesterone radioimmunoassay to the diagnosis and management of congenital adrenal hyperplasia, J. Pediatr. 88: 766–773.PubMedGoogle Scholar
  185. 185.
    McKenna, T.J., Jennings, A.S., Liddle, G.W., and Burr, I.M., 1976, Pregnenolone, 17-OH-pregnenolone, and testosterone in plasma of patients with congenital adrenal hyperplasia, J. Clin. Endocrinol. Metab. 42: 918–925.PubMedGoogle Scholar
  186. 186.
    Janoski, A., 1977, Naturally occurring adrenal steroids with salt-losing properties, in: Congenital Adrenal Hyperplasia (P.A. Lee, L.P. Plotnick, A.A. Kowarski, and C.J. Migeon, eds.) pp. 99–112, University Park Press, Baltimore.Google Scholar
  187. 187.
    Pham-Huu-Trung, M.T., Raux, M.C., Gourmelen, M., Baron, M., and Girard, F., 1976, Plasma aldosterone concentrations related to 17 α-hydroxyprogesterone in congenital adrenal hyperplasia, Acta. Endocrinol. 82: 572–586.PubMedGoogle Scholar
  188. 188.
    Parth, K., Zimprich, H., Swoboda, W., Brunei, R., and Bohrn, E., 1978, Congenital adrenal hyperplasia: Simultaneous determinations of plasma aldosterone and 17-hydroxyprogesterone, Acta Endocrinol. 87: 148–157.PubMedGoogle Scholar
  189. 189.
    Limai, J.M., Rappaport, R., and Bayard, F., 1977, Plasma aldosterone, renin activity and 17 α-hydroxyprogesterone in salt-losing congenital adrenal hyperplasia. I. Response to ACTH in hydrocortisone treated patients and effects of 9α-fluorocortisol, J. Clin. Endocrinol. Metab. 45: 551–559.Google Scholar
  190. 190.
    Rosier, A., Levine, L.S., Schneider, B., Novogroder, M., and New, M.I., 1977, The interrelationship of sodium balance, plasma renin activity and ACTH on congenital adrenal hyperplasia, J. Clin. Endocrinol. Metab. 45: 500–512.Google Scholar
  191. 191.
    Rayyis, S.S., and Horton, R., 1971, Effect of angiotensin II on adrenal and pituitary function in man, J. Clin. Endocrinol. Metab. 32: 539–546.PubMedGoogle Scholar
  192. 192.
    Hepp, R., Grillet, C., Peytremann, A., and Vallotton, M.B., 1977, Stimulation of corticosteroid biosynthesis by angiotensin I, [Des-Asp1]angiotensin I, angiotensin II and [Des-Asp1]angiotensin II in bovine adrenal fasciulata cells, Endocrinology 101: 717–725.PubMedGoogle Scholar
  193. 193.
    Gill, A., Ill, C.R., and Simonian, M.H., 1977, Angiotensin stimulation of bovine adrenocortical cell growth, Proc. Natl. Acad. Sci. U.S.A. 74: 5569–5573.PubMedGoogle Scholar
  194. 194.
    Beitins, I.Z., Bayard, F., Kowarski, A., and Migeon, C.J., 1972, The effect of ACTH administration on aldosterone production in non-salt losing congenital adrenal hyperplasia, J. Clin. Endocrinol. Metab. 35: 595–603.PubMedGoogle Scholar
  195. 195.
    Douglas, J., Aguilera, G., Kondo, T., and Catt, K., 1978, Angiotensin II receptors and aldosterone production in rat adrenal glomerulosa cells, Endocrinology 102: 685–696.PubMedGoogle Scholar
  196. 196.
    Klingensmith, G.J., Garcia, S.C., Jones, H.W., Migeon, C.J., and Blizzard, R.M., 1977, Glucocorticoid treatment of girls with congenital adrenal hyperplasia: Effects on height, sexual maturation, and fertility. J. Pediatr. 90: 996–1004.PubMedGoogle Scholar
  197. 197.
    Pang, S., Kenny, F.M., Foley, T.P., and Drash, A.L., 1977, Growth and sexual maturation in treated congenital adrenal hyperplasia, in: Congenital Adrenal Hyperplasia (P.A. Lee, L.P. Plotnick, A.A. Kowarski, and C.J. Migeon, eds.), pp. 233–246, University Park Press, Baltimore.Google Scholar
  198. 198.
    Ghali, I., David, M., and David, L., 1977, Linear growth and pubertal development in treated congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Clin. Endocrinol. 6: 425–436.Google Scholar
  199. 199.
    Styne, D.M., Richards, G.E., Bell, J.J., Conte, F.A., Morishema, A., Kaplan, S.L., and Grumback, M.M., 1977, Growth patterns in congenital adrenal hyperplasia: Correlation of glucocortiod therapy with stature, in: Congenital Adrenal Hyperplasia (P.A. Lee, L.P. Plotnick, A.A. Kowarski, and C.J. Migeon, eds.), pp. 247–261, University Park Press, Baltimore.Google Scholar
  200. 200.
    Huseman, C.A., Varma, M.M., Blizzard, R.M., and Johanson, A., 1977, Treatment of congenital virilizing adrenal hyperplasia patient with single and multiple daily doses of prednisone, J. Pediatr. 90: 538–542.PubMedGoogle Scholar
  201. 201.
    Bacon, G.E., Spencer, M.L., and Kelch, R.P., 1977, Effect of cortisol treatment on hormonal relationships in congenital adrenal hyperplasia, Clin. Endocrinol. 6: 113–126.Google Scholar
  202. 202.
    Korth-Schutz, S., Virdis, R., Saenger, P., Chow, D.M., Levine, L.S., and New, M.I., 1978, Serum androgens as a continuing index of adequacy of treatment of congenital adrenal hyperplasia, J. Clin. Endocrinol. Metab. 46: 452–458.PubMedGoogle Scholar
  203. 203.
    Roux, H., Loras, B., and Forest, M.G., 1977, Congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: Plasma I7α-hydroxyprogesterone in patients’ relatives, in: Congenital Adrenal Hyperplasia (P.A. Lee, L.P. Plotnick, A.A. Kowarski, and C.J. Migeon, eds.), pp. 487–494, University Park Press, Baltimore.Google Scholar
  204. 204.
    Knorr, D., Bidlingmaier, F., Butenandt, O., von Schnakenburg, K., and Wagner, W., 1977, Tests for heterozygosity of congenital adrenal hyperplasia, in: Congenital Adrenal Hyperplasia (P.A. Lee, L.P. Plotnick, A.A. Kowarski, and C.J. Migeon, eds.), pp. 495–500, University Park Press, Baltimore.Google Scholar
  205. 205.
    Gutai, J.P., Kowarski, A.A., and Migeon, C.J., 1977, The detection of the heterozygous carrier for congenital virilizing adrenal hyperplasia, J. Pediatr. 90: 924–929.PubMedGoogle Scholar
  206. 206.
    Gutai, J.P., Kowarski, A.A., and Migeon, C.J., 1977, Detection of heterozygote carrier for congenital virilizing adrenal hyperplasia, in: Congenital Adrenal Hyperplasia (P.A. Lee, L.P. Plotnick, A.A. Kowarski, and C.J. Migeon, eds.), pp. 501–508, University Park Press, Baltimore.Google Scholar
  207. 207.
    Krensky, A.M., Bongiovanni, A.M., Marino, J., Parks, J., and Tenore, A., 1977, Identification of heterozygote carriers of congenital adrenal hyperplasia by radioimmunoassay of serum 17-OH progesterone, J. Pediatr. 90: 930–933.PubMedGoogle Scholar
  208. 208.
    Homoki, J., Fazekas, A.T.A., and Tiller, W.M., 1977, Urinary excretion of pregnanetriolone in parents of children with 21-hydroxylase deficiency before and after stimulation with adrenocorticotropic hormone, in: Congenital Adrenal Hyperplasia (P.A. Lee, L.P. Plotnick, A.A. Kowarski, and C.J. Migeon, eds.), pp. 479–486, University Park Press, Baltimore.Google Scholar
  209. 209.
    Koizumi, S., Kyoya, S., Miyawaki, T., Kidani, H., Funabashi, T., Nakashima, H., Nakanuma, Y., Otha, G., Itagaki, E., and Katagiri, M., 1977, Cholesterol side-chain cleavage enzyme activity and cytochrome P-450 content in adrenal mitochondria of a patient with congenital lipoid adrenal hyperplasia, Clin. Chim. Acta 77: 301–306.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1979

Authors and Affiliations

  • John T. Gwynne
    • 1
  • Robert L. Ney
    • 1
  1. 1.Department of MedicineUniversity of North CarolinaChapel HillUSA

Personalised recommendations